G-CON Manufacturing and Just – Evotec Biologics Complete the Installation of Cleanroom PODs® for the First J.POD® Facility in North America


Just – Evotec Biologics’ Redmond, Washington site offers true meaning to “Facility of the Future” with flexible and podular manufacturing of clinical and commercial-stage biologics.


College Station, Texas, and Redmond, Washington, USA, 16 March 2021:
G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, announced today that it has successfully delivered and installed multiple PODs to Just – Evotec Biologics, a wholly-owned Seattle-based company of Evotec SE. The delivery advances the completion of the first J.POD® manufacturing facility in North America, a one-of-a-kind cGMP biomanufacturing facility that features small intensified bioprocessing operations housed inside G-CON cleanroom PODs. The news comes just weeks after Evotec’s announcement of Just – Evotec Biologics’ expanded contract with the Department of Defense for the manufacturing of anti-SARS-CoV-2 monoclonal antibodies.

As a true “Facility of the Future,” the J.POD® facility features a flexible platform design that offers capacity scaling with additional PODs in the future and allows Just – Evotec Biologics to efficiently adapt and respond to changes in manufacturing demand for themselves and their clients.

“We feel honored and privileged to work on this true facility of the future,” said Maik Jornitz, CEO of G-CON Manufacturing Inc. “The Just – Evotec Biologics team’s vision is very much aligned with ours and we enjoy the close work together for a common goal. Just – Evotec Biologics has adopted our cleanroom PODs as an integral component of their manufacturing technology platform and we appreciate their trust.”

“The arrival of the PODs built and delivered by the exceptional team at G-CON represents another milestone in the construction of our first J.POD® facility in North America and a significant leap to accelerate drug development and expand biotherapeutic access to a greater patient population,” said Jim Thomas, Executive Vice President and Global Head of Biotherapeutics at Just – Evotec Biologics.

Keeping true to its commitment, G-CON placed twelve (12) PODs in less than one week at the Just - Evotec Biologics site in Redmond, WA and within one year from the project kick-off.


For the full version of G-CON's press release, please follow this link.